Analysis of nuclear nestin localization in cell lines derived from neurogenic tumors

. 2011 Aug ; 32 (4) : 631-9. [epub] 20110222

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid21340483

Nestin is a class VI intermediate filament protein expressed in the cytoplasm of stem and progenitor cells in the mammalian CNS during development. In adults, nestin is present only in a small subset of cells and tissues, including the subventricular zone of the adult mammalian brain, where neurogenesis occurs. Nestin expression has also been detected under such pathological conditions as ischemia, inflammation, and brain injury, as well as in various types of human solid tumors and their corresponding cell lines. Furthermore, nestin was recently found in the nuclei of glioblastoma, neuroblastoma, and angiosarcoma cells and it was proved to interact directly with the nuclear DNA in neuroblastoma cells. Here, we perform the first study of the intracellular distribution of nestin in cell lines derived from neurogenic tumors. Using immunodetection methods, we examined nestin expression in tumor-derived cell lines obtained from 11 patients with neuroblastoma, medulloblastoma, or glioblastoma multiforme. Besides its standard cytoplasmic localization, nestin was present in the nuclei of two neuroblastoma cell lines and one medulloblastoma cell line. Nestin was only present in the nuclei of cells with diffuse cytoplasmic staining for this protein, and the proportion of cells positive for nestin in nuclei, as well as the intensity of staining, varied. The presence of nestin in the nuclei was confirmed by both transmission electron microscopy and Western blotting. Our results indicate that the presence of nestin in the nuclei of tumor cells is not very rare, especially under in vitro conditions.

Zobrazit více v PubMed

Mol Cell Biol. 2003 Jul;23(14):5090-106 PubMed

J Biol Chem. 2001 May 11;276(19):16456-63 PubMed

Cell Tissue Res. 2004 Jun;316(3):369-76 PubMed

J Neurosci. 2004 Mar 3;24(9):2143-55 PubMed

EMBO J. 2006 Oct 18;25(20):4808-19 PubMed

Oncol Rep. 2009 Jan;21(1):119-27 PubMed

Cell. 1992 Sep 18;70(6):949-59 PubMed

Cancer Res. 1992 Oct 1;52(19):5334-41 PubMed

Mol Cell Biol. 1994 Sep;14(9):6297-305 PubMed

BMC Cancer. 2006 Feb 02;6:32 PubMed

J Clin Pathol. 2005 Feb;58(2):222-3 PubMed

J Biol Chem. 2004 Jul 2;279(27):27994-9 PubMed

Neoplasma. 2010;57(4):291-8 PubMed

J Neurooncol. 2008 Jan;86(1):31-45 PubMed

J Biomol Struct Dyn. 1992 Dec;10(3):505-31 PubMed

Virchows Arch. 2008 Jul;453(1):33-41 PubMed

J Cell Sci. 1992 Oct;103 ( Pt 2):589-97 PubMed

J Invest Dermatol. 2011 Feb;131(2):487-94 PubMed

Mod Pathol. 2005 Dec;18(12):1599-605 PubMed

J Neurooncol. 2006 Dec;80(3):227-33 PubMed

J Cell Sci. 1998 Jul 30;111 ( Pt 14):1951-61 PubMed

Lab Invest. 2002 Mar;82(3):345-51 PubMed

Oncol Rep. 2010 Jan;23(1):17-24 PubMed

Chem Senses. 2005 Oct;30(8):707-17 PubMed

J Biol Chem. 1999 Apr 2;274(14):9881-90 PubMed

J Clin Pathol. 2008 Apr;61(4):467-73 PubMed

J Cell Sci. 1998 Dec 18;111 ( Pt 24):3573-84 PubMed

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Nestin as a marker of cancer stem cells

. 2015 Jul ; 106 (7) : 803-11. [epub] 20150526

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace